2025-03-16

Automated Phenoconversion Arrives: Real-Time, Context-Aware Drug-Response Scoring in Every Base Model

Product News | Published: Mar 16, 2025

news image

Precision pharmacogenomics is more than static genotypes. Today we’re excited to announce that PGxAI’s base models now include built-in phenoconversion: our engine automatically adjusts genotype-derived phenotypes in real time by accounting for co-medications, inhibitors/inducers, and other clinical factors.

The result is a dynamic, context-aware sensitivity score that tracks each individual’s evolving drug-response profile rather than a one-off prediction. Phenoconversion runs natively in our web terminal and scales to high-throughput workloads through the same REST API you already use for bulk uploads and report retrieval.

We see this as a pivotal step toward eliminating adverse reactions caused by overlooked drug-drug interactions and metabolic shifts. Whether you need a single compound check or automated, panel-wide decision support, phenoconversion is now just an upload-or an API call-away.

Ready to integrate or learn more? Reach out via our contact form and let’s accelerate safer, smarter therapeutics together.

Success Stories
Serving Every Stakeholder in Healthcare
image
logo
Press Release
2026-01-21
PGxAI and Novo Genomics scale AI‑enabled pharmacogenomics across Saudi Arabia
image
logo
Press Release
2025-12-22
PGxAI and Mahd Sports Academy announce strategic partnership to advance AI‑enabled sports genomics across Saudi Arabia
image
logo
News
2025-11-17
PGxAI and Lean Business Services Partner to Scale AI Pharmacogenomics in Saudi Arabia
image
logo
Event
2025-11-01
PGxAI Selected as a Finalist at the HLTH USA 2025 Startup Pitch Tournament
image
logo
Press Release
2025-10-13
PGxAI and Najashi Holding partner to advance precision medicine in Saudi Arabia
image
logo
News
2025-10-01
PGxAI Welcomes Roni Zeiger as Product Strategy Advisor
image
logo
News
2025-09-18
PGxAI Admitted to Creative Destruction Lab (CDL) Seattle - Computational Health 2025-2026
image
logo
News
2025-09-03
PGxAI Welcomes John Quackenbush as Scientific Advisor
image
logo
Press Release
2025-08-19
PGxAI and Sequencing.com Announce Strategic Partnership to Advance Affordable Pharmacogenomics
image
logo
News
2025-08-16
PGxAI Named a Key Player in Straits Research’s Pharmacogenomics (PGX) Market Report
image
logo
News
2025-08-03
PGxAI Welcomes David Blumenthal as Scientific Advisor
image
logo
News
2025-07-18
Benchmarking LLMs for Pharmacogenomic (PGx) Recommendations
image
logo
News
2025-07-04
AI & Multi-Omics in Pharmacogenomics: PGxAI’s New Review
image
logo
Press Release
2025-06-27
PGxAI Unveils Betelgeuse - New AI Model for Real-Time Clinical Outcome Analysis and Adaptive Recommendations
image
logo
News
2025-06-14
Upload Your Own Genetic Data: Instant Drug-Sensitivity Insights Now in All Base Models
image
logo
News
2025-05-16
Drug-Drug Interaction Module-FDA-Label Powered, Terminal-Ready-Now Live in All Open Models
image
logo
News
2025-04-23
PGxAI Unveils AI-Driven Genetic Tool to Personalize GLP-1 Drugs Including Ozempic®
image
logo
News
2025-04-15
PGxAI Debuts Deneb, an AI Model Revolutionizing Drug Development for Biopharma
image
logo
News
2025-03-16
Automated Phenoconversion Arrives: Real-Time, Context-Aware Drug-Response Scoring in Every Base Model
image
logo
News
2025-02-28
PGxAI Debuts Vega, an AI Model Set to Disrupt Precision Medicine
image
logo
Press Release
2024-12-24
Revolutionizing Precision Medicine: PGxAI Raises $1.5 Million in Funding for AI-Powered Pharmacogenetics Platform
image
logo
News
2024-12-21
The Ventures Award: The World's Premier Stage for Startup Excellence
image
logo
Press Release
2024-12-19
PGxAI Launches Sirius, an AI‑Powered Pharmacogenetics Model
image
logo
Press Release
2024-06-25
IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration